SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001564590-19-022662
Filing Date
2019-06-17
Accepted
2019-06-17 16:30:58
Documents
2
Period of Report
2019-05-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K/A ovid-8ka_20190617.htm 8-K/A 32833
2 EX-10.1 ovid-ex101_6.htm EX-10.1 39066
  Complete submission text file 0001564590-19-022662.txt   73025
Mailing Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036
Business Address 1460 BROADWAY SUITE 15044 NEW YORK NY 10036 212-776-4381
Ovid Therapeutics Inc. (Filer) CIK: 0001636651 (see all company filings)

IRS No.: 465270895 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-38085 | Film No.: 19901715
SIC: 2834 Pharmaceutical Preparations